MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.apsb.2020.05.004

Медицинская библиотека · Acta pharmaceutica Sinica. B · 2020

Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.

Jiang Tingting, Wang Guan, Liu Yao, Feng Lu, Wang Meng, Liu Jie, Chen Yi, Ouyang Liang

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Tropomyosin receptor kinase A, B and C (TRKA, TRKB and TRKC), which are well-known members of the cell surface receptor tyrosine kinase (RTK) family, are encoded by the neurotrophic receptor tyrosine kinase 1, 2 and 3 (NTRK1, NTRK2 and NTRK3) genes, respectively. TRKs can regulate cell proliferation, differentiation and even apoptosis through the RAS/MAPKs, PI3K/AKT and PLCγ pathways. Gene fusions involving NTRK act as oncogenic drivers of a broad diversity of adult and pediatric tumors, and TRKs have become promising antitumor targets. Therefore, achieving a comprehensive understanding of TRKs and relevant TRK inhibitors should be urgently pursued for the further development of novel TRK inhibitors for potential clinical applications. This review focuses on summarizing the biological functions of TRKs and NTRK fusion proteins, the development of small-molecule TRK inhibitors with different chemotypes and their activity and selectivity, and the potential therapeutic applications of these inhibitors for future cancer drug discovery efforts.

Для цитирования: Jiang Tingting, Wang Guan, Liu Yao, Feng Lu, Wang Meng, Liu Jie, Chen Yi, Ouyang Liang. Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers.. Acta pharmaceutica Sinica. B. 2020. DOI: 10.1016/j.apsb.2020.05.004.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.